Follow

Recently wrote for this postmortem of the Oxford/AZ mucosal Covid vaccine trial. The intranasal spray version of ChAdOx1 failed to induce strong antibody responses.

But the column also includes a bit on the positive outcome of CanSino's trial using an inhaler (approved as a booster for 2x Coronavac).

nature.com/articles/d41591-022

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.